Biblio
“Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 2, pp. 615-631, 2017.
, “Alterations of Effective Connectivity Patterns in Mild Cognitive Impairment: An MEG Study.”, J Alzheimers Dis, vol. 65, no. 3, pp. 843-854, 2018.
, “Altered Affective Evaluations of Smells in Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 433-41, 2016.
, “Altered Brain Activities Associated with Neural Repetition Effects in Mild Cognitive Impairment Patients.”, J Alzheimers Dis, vol. 53, no. 2, pp. 693-704, 2016.
, “Altered Energy Metabolism Pathways in the Posterior Cingulate in Young Adult Apolipoprotein E ɛ4 Carriers.”, J Alzheimers Dis, vol. 53, no. 1, pp. 95-106, 2016.
, “Altered Executive Function in Pre-Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 54, no. 3, pp. 933-940, 2016.
, “Altered Expression of Circulating Cdc42 in Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1477-1483, 2018.
, “Altered Expression of Urea Cycle Enzymes in Amyloid-β Protein Precursor Overexpressing PC12 Cells and in Sporadic Alzheimer's Disease Brain.”, J Alzheimers Dis, vol. 62, no. 1, pp. 279-291, 2018.
, “Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer's Mouse Model.”, J Alzheimers Dis, vol. 56, no. 2, pp. 775-788, 2017.
, “Altered Gut Microbiota in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1241-1257, 2017.
, “Altered microRNA, mRNA, and Protein Expression of Neurodegeneration-Related Biomarkers and Their Transcriptional and Epigenetic Modifiers in a Human Tau Transgenic Mouse Model in Response to Developmental Lead Exposure.”, J Alzheimers Dis, vol. 63, no. 1, pp. 273-282, 2018.
, “Altered Neuronal Activity Patterns of the Prefrontal Cortex in Alzheimer's Disease After Transcranial Alternating Current Stimulation: A Resting-State fMRI Study.”, J Alzheimers Dis, 2024.
, “Altered sense of humor in dementia.”, J Alzheimers Dis, vol. 49, no. 1, pp. 111-9, 2016.
, “Altered Sphingolipid Balance in Capillary Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 60, no. 3, pp. 795-807, 2017.
, “Altered Topology in Information Processing of a Narrated Story in Older Adults with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 53, no. 2, pp. 517-33, 2016.
, “An Alternative View of Familial Alzheimer's Disease Genetics.”, J Alzheimers Dis, vol. 96, no. 1, pp. 13-39, 2023.
, “Aluminum and Amyloid-β in Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1627-1635, 2020.
, “Aluminum and Neurofibrillary Tangle Co-Localization in Familial Alzheimer's Disease and Related Neurological Disorders.”, J Alzheimers Dis, vol. 78, no. 1, pp. 139-149, 2020.
, “Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome.”, J Alzheimers Dis, vol. 61, no. 2, pp. 631-644, 2018.
, “Alzheimer's Amyloid-β is an Antimicrobial Peptide: A Review of the Evidence.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1495-1506, 2018.
, “Alzheimer's and Parkinson's Diseases and the Risk of Cancer: A Cohort Study.”, J Alzheimers Dis, vol. 72, no. 4, pp. 1269-1277, 2019.
, “Alzheimer's and Parkinson's Diseases: Expected Economic Impact on Europe-A Call for a Uniform European Strategy.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1123-1133, 2016.
, “Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.”, J Alzheimers Dis, vol. 62, no. 3, pp. 965-992, 2018.
, “Is Alzheimer's Disease a Liver Disease of the Brain?”, J Alzheimers Dis, vol. 75, no. 1, pp. 1-14, 2020.
, “Alzheimer's Disease: A Systems View Provides a Unifying Explanation of Its Development.”, J Alzheimers Dis, vol. 91, no. 1, pp. 43-70, 2023.
,